Outlooks on Three-Dimensional Printing for Ocular Biomaterials Research
Name
jop.2018.0142.pdf
Description
Published version
Size
781.34 KB
Format
Adobe PDF
Checksum (MD5)
2b363529e6421c9f9396e8d173ae3dd7
Author(s)
Fenton, Owen S
Paolini, Marion
Andresen, Jason L
Müller, Florence J
Langer, Robert
Date Issued
2020
Journal
Journal of Ocular Pharmacology and Therapeutics
Publisher
Mary Ann Liebert Inc
Version
Final published version
Abstract
© Copyright 2020, Mary Ann Liebert, Inc., publishers 2020. Given its potential for high-resolution, customizable, and waste-free fabrication of medical devices and in vitro biological models, 3-dimensional (3D) bioprinting has broad utility within the biomaterials field. Indeed, 3D bioprinting has to date been successfully used for the development of drug delivery systems, the recapitulation of hard biological tissues, and the fabrication of cellularized organ and tissue-mimics, among other applications. In this study, we highlight convergent efforts within engineering, cell biology, soft matter, and chemistry in an overview of the 3D bioprinting field, and we then conclude our work with outlooks toward the application of 3D bioprinting for ocular research in vitro and in vivo.
MIT Department
Koch Institute for Integrative Cancer Research at MIT
Massachusetts Institute of Technology. Department of Chemistry
Massachusetts Institute of Technology. Department of Chemical Engineering
Massachusetts Institute of Technology. Institute for Medical Engineering & Science
Harvard University--MIT Division of Health Sciences and Technology
Terms of Use
Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
Persistent DSpace Link
DOI of Published Version
10.1089/JOP.2018.0142
https://doi.org/10.1089/JOP.2018.0142
